Connect with our Cancer Team 24/7

Call us at (888) 777-4167

Henry Ford Leads Multi-Institutional Pancreatic Cancer Consortium

Advancing pancreatic cancer research for early detection and new therapies.

Pancreatic cancer is a devastating disease with a five-year survival rate of roughly 8 percent. With no effective screening tool currently available to detect pancreatic cancer early, most patients are not diagnosed until the cancer has progressed to an advanced stage.

Never has there been a greater opportunity to offer more patients hope in the fight against pancreatic cancer.

The Henry Ford Pancreatic Cancer Center aims to do just that by leading a global, multi-institutional research consortium. Funded by an initial $20 million gift from an anonymous individual donor, the consortium will lead research initiatives to develop new tools for early detection of pancreatic cancer.

Our Vision

Bring together the best minds in the world to detect pancreatic cancer earlier and help patients live longer.

Learn More

Steps to discover, develop and lead to early detection

 

Led by David Kwon, M.D., Director of Surgical Oncology, Henry Ford Cancer Institute, and Director, Multidisciplinary Pancreas Clinic at Henry Ford Hospital, the consortium will focus on four key areas:

pancreatic cancer graphic

As leaders of the consortium, Henry Ford will leverage its clinical and organizational resources to strengthen its research and partnerships, including:

  • Henry Ford Innovation Institute, which has cultivated an extensive global network, including relationships with healthcare leaders, entrepreneurs and investors in Saudi Arabia, India, and, Israel.
  • Henry Ford Cancer Institute’s Precision Medicine Program, the first and most comprehensive in Michigan to offer genomic testing and expertise of a molecular tumor board to all cancer patients.
  • Henry Ford Health System’s participation in All of Us, a National Institutes of Health Precision Medicine research program.
  • Henry Ford Health System’s Department of Public Health Sciences, which conducts and promotes population and clinical research studies to advance biomedical knowledge that will result in disease prevention and overall improved health status.

Precision Medicine

Precision Medicine works to find targeted treatments custom-fit for each person’s unique type of cancer. Discover the advances Henry Ford is bringing to all patients.

Learn More

All of Us Research Program

Henry Ford is among a few select health systems in the nation to participate in this program. We’re calling on one million people across America to help us advance how we prevent and treat diseases for generations to come.

Sign Up